These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 29482074)
1. A change in structural integrity of c-Kit mutant D816V causes constitutive signaling. Raghav PK; Singh AK; Gangenahalli G Mutat Res; 2018 Mar; 808():28-38. PubMed ID: 29482074 [TBL] [Abstract][Full Text] [Related]
2. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit. Pedersen M; Rönnstrand L; Sun J Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823 [TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant. Chian R; Young S; Danilkovitch-Miagkova A; Rönnstrand L; Leonard E; Ferrao P; Ashman L; Linnekin D Blood; 2001 Sep; 98(5):1365-73. PubMed ID: 11520784 [TBL] [Abstract][Full Text] [Related]
4. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Kozlowski M; Larose L; Lee F; Le DM; Rottapel R; Siminovitch KA Mol Cell Biol; 1998 Apr; 18(4):2089-99. PubMed ID: 9528781 [TBL] [Abstract][Full Text] [Related]
5. Stem cell factor and NSC87877 synergism enhances c-Kit mediated proliferation of human erythroid cells. Raghav PK; Singh AK; Gangenahalli G Life Sci; 2018 Dec; 214():84-97. PubMed ID: 30308182 [TBL] [Abstract][Full Text] [Related]
6. The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V. Agarwal S; Kazi JU; Mohlin S; Påhlman S; Rönnstrand L Oncogene; 2015 Aug; 34(35):4581-90. PubMed ID: 25435369 [TBL] [Abstract][Full Text] [Related]
7. Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells. Scholl S; Kirsch C; Böhmer FD; Klinger R J Cancer Res Clin Oncol; 2004 Dec; 130(12):711-8. PubMed ID: 15340843 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Piao X; Paulson R; van der Geer P; Pawson T; Bernstein A Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14665-9. PubMed ID: 8962111 [TBL] [Abstract][Full Text] [Related]
9. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor. Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052 [TBL] [Abstract][Full Text] [Related]
10. Mutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanisms. Laine E; Chauvot de Beauchêne I; Perahia D; Auclair C; Tchertanov L PLoS Comput Biol; 2011 Jun; 7(6):e1002068. PubMed ID: 21698178 [TBL] [Abstract][Full Text] [Related]
11. Src-like-adaptor protein (SLAP) differentially regulates normal and oncogenic c-Kit signaling. Kazi JU; Agarwal S; Sun J; Bracco E; Rönnstrand L J Cell Sci; 2014 Feb; 127(Pt 3):653-62. PubMed ID: 24284075 [TBL] [Abstract][Full Text] [Related]
12. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. Linnekin D; DeBerry CS; Mou S J Biol Chem; 1997 Oct; 272(43):27450-5. PubMed ID: 9341198 [TBL] [Abstract][Full Text] [Related]
13. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells. Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Lennartsson J; Blume-Jensen P; Hermanson M; Pontén E; Carlberg M; Rönnstrand L Oncogene; 1999 Sep; 18(40):5546-53. PubMed ID: 10523831 [TBL] [Abstract][Full Text] [Related]
16. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST). Ali S; Ali S Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849 [TBL] [Abstract][Full Text] [Related]
17. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Samayawardhena LA; Hu J; Stein PL; Craig AW Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778 [TBL] [Abstract][Full Text] [Related]
18. Stem cell factor and NSC87877 combine to enhance c-Kit mediated proliferation of human megakaryoblastic cells. Raghav PK; Singh AK; Gangenahalli G PLoS One; 2018; 13(11):e0206364. PubMed ID: 30388134 [TBL] [Abstract][Full Text] [Related]
19. The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders. Roskoski R Pharmacol Res; 2018 Jul; 133():35-52. PubMed ID: 29704617 [TBL] [Abstract][Full Text] [Related]